- 3
-
Efficacy of 48-week clevudine therapy for chronic hepatitis B
-
Min Hwan Kim, M.D., Kyung-Ah Kim, M.D., June Sung Lee, M.D.,
Hyun Woong Lee, M.D. Hyung Joon Kim, M.D. Sang Gu Yun, M.D.,
Nam-Hoon Kim, M.D., Won Ki Bae, M.D., Young Soo Moon, M.D.
-
Clin Mol Hepatol. 2009;15(3):331-337. Published online September 30, 2009
-
-
-
Long-term clevudine therapy in nucleos(t)ide-naive and Lamivudine-experienced patients with hepatitis B virus-related chronic Liver diseases
-
Heon Ju Lee, M.D., Jong Ryul Eun, M.D., Chang Hyeong Lee, M.D. Jae Seok Hwang, M.D.
Jeong Ill Suh, M.D. Byung Seok Kim, M.D. Byoung Kuk Jang, M.D.
Departments of
-
Clin Mol Hepatol. 2009;15(2):179-192. Published online June 30, 2009
-
-
-
Distribution of hepatitis B virus genotypes in Korea
-
Ji-Hyun Cho, M.D. Kui-Hyun Yoon, M.D. Key-Earn Lee, M.D.
Do-Sim Park, M.D. Young-Jin Lee, M.D. Hyung-Bae Moon, M.D.
Kyoung R. Lee, M.D. Chang-Soo Choi, M.D. Eun-Young Cho, M.D.
Haak-Cheoul Kim, M.D.
-
Clin Mol Hepatol. 2009;15(2):140-147. Published online June 30, 2009
-
-
-
Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation
-
Seong Yong Woo , Se Hyun Cho , Se Min Lee , Myoung Beom Koh , Chee Ho Noh , Chang Wook Kim , Jong Young Choi , Jin Mo Yang , Joon Yeol Han , Young Sok Lee
-
Clin Mol Hepatol. 2009;15(2):131-139. Published online June 30, 2009
-
-
- 3
-
Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea
-
Byung Kook Kim, M.D., So Young Kwon, M.D., Chang Hong Lee, M.D.,
Won Hyeok Choe, M.D., Hong Mi Choi, M.S. Hye Won Koo, M.D.
-
Clin Mol Hepatol. 2009;15(1):25-41. Published online March 31, 2009
-
-
- 3
-
Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients
-
Jin Hee Cho, M.D., Jae Youn Cheong, M.D., Joon Koo Kang, M.D., Jin Sun Park, M.D.,
Myoung Hee Lee, M.D., Nam Kyu Lim, M.D., Sun Pyo Hong. Soo-Ok Kim.
Wang Don Yoo. and Sung Won Cho, M.D.
-
Clin Mol Hepatol. 2008;14(1):58-66. Published online March 20, 2008
-
-
-
Change of HBV DNA Level as a Predictor of HBeAg Loss after Lamivudine Treatment
-
Jae Kwon Jung, M.D., Chang Hyeong Lee, M.D., Eun Young Kim, M.D.,
Jin Tae Jung, M.D., Joon Hyuck Choi, M.D., Ji Min Han, M.D.,
Myoung In Jin, M.D., Ju Yeon Cho, M.D., Byung Seok Kim, M.D., Im Hee Shin, Ph.D.
-
Clin Mol Hepatol. 2007;13(4):513-520. Published online December 20, 2007
-
-
View: 3230
Download: 28
-
The Efficacy and Safety of Telbivudine in Korean Patients with Chronic Hepatitis B
-
Young-Myoung Moon, M.D. Seong-Gyu Hwang, M.D. Boo-Sung Kim, M.D.
Kyu-Sung Rim, M.D. Mong Cho, M.D. Dong-Joon Kim, M.D. Joon-Yeol Han, M.D.
Young-Seok Kim, M.D. Ho-Soon Choi, M.D. Sang-Hoon Ahn, M.D.
-
Clin Mol Hepatol. 2007;13(4):503-512. Published online December 20, 2007
-
-
- 3
-
Detection of Intrahepatic HBV DNA in HBsAg-negative Liver Diseases
-
Yun Soo Kim, M.D., Jae Young Jang, M.D. Soo Hoon Eun M.D. Young Koog Cheon, M.D.
Young Seok Kim, M.D. Jong Ho Moon, M.D. Young Deok Cho, M.D. So-Young Jin, M.D.
Chan Sup Shim, M.D. Boo Sung Kim, M.D.
-
Clin Mol Hepatol. 2006;12(2):201-208. Published online January 1, 1970
-
-
View: 2026
Download: 17
|